Early stage drug development company Redx Pharma has been awarded a £4.7 million grant from the UK Government's Regional Growth Fund (RGF) to support the launch of a new £10.8 million research and development centre focused on anti-viral and anti-bacterial drugs.
The funding will enable the establishment of a new subsidiary, Redx Anti-Infectives Ltd, which will create 119 high value science jobs, based in Liverpool. The posts will be within chemistry, biochemistry and analytical testing. A further 28 specialist jobs are expected to be created within the wider supply chain.
The RGF support will be mirrored by £6.1 million of new private investment brokered by Manchester-based Acceleris Corporate Finance and sourced from a combination of commercial partnering revenue and shareholder equity.
This is the second successful award for Redx having previously won RGF backing for the launch of its first spin out, Redx Oncology Ltd, a cancer research and development subsidiary which currently employs more than 50 people in Liverpool.
beBRAND has advised Redx Pharma since its launch in 2010 and congratulates the company on yet another great achievement.
"This Is Squash" initiative for London schools has been nominated for an international award that celebrates the positive and sustainable social change that can come from sport. Spirit of Squash has reached out to communities across London running projects at schools in Islington, Clerkenwell and Westminster. The sessions give kids the chance to exercise, develop co-ordination & concentration and have fun.
In the first six months of 2012 SoS have introduced more than 1500 children to squash. These are kids that have never heard of the sport before and typically have limited, if any, access to sporting opportunity.
Voting is now open to everyone until 5 September. Have a look at the web site for more information: SportsMarketing360.com
And vote for SPIRIT OF SQUASH! The winners will be announced following Sports Marketing 360 on 27 September.
Spirit of Squash's brand identity was designed by beBRAND and we support their marketing and promotional activities.
RedxOncology.com launched today, designed and managed by beBRAND. The site is the first formal appearance of the company name ahead of Redx Oncology Ltd opening for business on 2 April. They are a subsidiary of Redx Pharma, a UK-based company developing new drug candidates using the broad-based potential of their innovative Redox Switch platform. beBRAND has advised Redx Pharma since 2010, developing the naming structure, identity and marketing materials. This phase of work included the production of Brand Guidelines for both parent and subsidiary, and the creation of a distinctive and flexible structure for future subsidiary companies.